Respiratory support in the emergency department a systematic review and meta-analysis.

Publication date: Mar 22, 2024

An estimated 20% of emergency department (ED) patients require respiratory support (RS). Evidence suggests that nasal high flow (NHF) reduces RS need. This review compared NHF to conventional oxygen therapy (COT) or noninvasive ventilation (NIV) in adult ED patients. The systematic review (SR) and meta-analysis (MA) methods reflect the Cochrane Collaboration methodology. Six databases were searched for randomized controlled trials (RCTs) comparing NHF to COT or NIV use in the ED. Three summary estimates were reported: (1) need to escalate care, (2) mortality, and (3) adverse events (AEs). This SR and MA included 18 RCTs (n = 1874 participants). Two of the five MA conclusions were statistically significant. Compared with COT, NHF reduced the risk of escalation by 45% (RR 0. 55; 95% CI [0. 33, 0. 92], p = . 02, NNT = 32); however, no statistically significant differences in risk of mortality (RR 1. 02; 95% CI [0. 68, 1. 54]; p = . 91) and AE (RR 0. 98; 95% CI [0. 61, 1. 59]; p = . 94) outcomes were found. Compared with NIV, NHF increased the risk of escalation by 60% (RR 1. 60; 95% CI [1. 10, 2. 33]; p = . 01); mortality risk was not statistically significant (RR 1. 23, 95% CI [0. 78, 1. 95]; p = . 37). Evidence-based decision-making regarding RS in the ED is challenging. ED clinicians have at times had to rely on non-ED evidence to support their practice. Compared with COT, NHF was seen to be superior and reduced the risk of escalation. Conversely, for this same outcome, NIV was superior to NHF. However, substantial clinical heterogeneity was seen in the NIV delivered. Research considering NHF versus NIV is needed. COVID-19 has exposed the research gaps and slowed the progress of ED research.

Concepts Keywords
Clinicians COVID‐19
Covid emergency
Heterogeneity meta‐analysis
nasal high flow
oxygenation
respiratory
systematic review

Semantics

Type Source Name
disease MESH emergency
drug DRUGBANK Oxygen
disease MESH COVID-19

Original Article

(Visited 1 times, 1 visits today)